Courtney Yeager
John Kekel
Mr. Kekel is a driven leader with a proven track record in building interpersonal relationships by managing, teaching and training creative innovative strategies resulting in resolved business issues, organizational competence and efficiency. He has trained over 1 million business owners and entrepreneurs in 6 countries.
He is the proud father of 5 children and has 9 grandchildren whom he spoils on a regular basis. He spends his free time hiking new trails and riding his dirt bike.
Adam Fichman
William Tancredi
Derrick Kraemer
Alisar Zahr
Dr. Alisar S. Zahr is the Senior Director of Research and Clinical Development at Revision Skincare®. She is responsible for product innovations, formulation, and conducting clinical studies for new product launches as well as marketed products. She is responsible for a team of clinical scientists focused on disruptive innovation and measurable clinical results. Dr. Zahr collaborates with marketing, international, domestic, and strategic sales to ensure the product innovations and benefits can be translated to physicians, their staff, and patients.
Dr. Zahr is considered a subject matter expert in formulation of sun-care products as well as anti-aging treatment innovations. Throughout her career in the personal cosmetics industry, she has formulated and successfully brought products to the market, such as Neutrogena, Roc, Clean & Clear, Aveeno, and eltaMD. As evident from Dr. Zahr’s prior work experience, she is passionate about cosmetics and is focused on creating products for healthy, beautiful skin.
Dr. Zahr received a Bachelor of Science in Chemical Engineering at Villanova University and her Ph.D. in Chemical Engineering from The Pennsylvania State University, under the leadership of Dr. Michael Pishko. She has also received post-doctoral training at the University of California Santa Barbara (UCSB) under the mentorship of Dr. Samir Mitragotri and at Schepens Eye Research Institute an affiliate of Harvard Medical School, Department of Ophthalmology under
the mentorship of both Dr. Patricia D’Amore and Dr. Pablo Argueso. She has published papers in peer-reviewed journals and patented innovations while at PSU, UCSB, Schepens Eye Research Institute and Johnson & Johnson Consumer Products.
Sriram Viswanathan
Sriram Viswanathan has more than 30 years of technology business operations and venture capital experience. Prior to Celesta, Sriram was the founder of IndusAge Partners, a cross border venture firm investing in innovative companies in the US-India Technology corridor. Sriram spent nearly 20 years at Intel Corporation in various senior management roles, including vice president of the Intel Architecture Group (IAG), vice president of Intel Capital and general manager of Intel’s Incubation and Innovation Group.
Sriram is an active Advisory Board member of the India Semiconductor Mission, an initiative led by the Indian Government under Prime Minister Modi, guiding the development of a robust semiconductor and display manufacturing ecosystem in India. He also serves on the boards of the Aravind Eye Foundation and the World Affairs Council/ Commonwealth Club of California.
Sriram holds an MBA from UCLA Anderson School of Business (1997) and degrees in physics, computer science, and automation from the American College and the Indian Institute of Science in India.